戻る Agenda
SLS01 ICH 30th Anniversary: Summary of 30 Years and Future Prospects with the Role of Japan
Session Chair(s)
Kazuhiko Mori, PHD, MSC
Business Manager, "Toyama, the Silicon Valley of Medicine" Creative Consortium Management Office, Japan
Toshiyoshi Tominaga, PHD
Life Science Department, Advisor, Sunflare, Japan
Speaker(s)
Lenita Lindström, LLM
ICH Assembly Chair and Senior Expert, European Commission, European Commission, Belgium
Celia Lourenco, PHD
Director General, Biologic and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada, Canada
Nobumasa Nakashima
Professor, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan
Hironobu Hiyoshi, PHD
Member of the ICH Management Committee and of the Assembly , Japan Pharmaceutical Manufacturers Association (JPMA), Japan
Theresa Mullin, PHD
Associate Center Director - CDER, FDA, United States
Naoyuki Yasuda, MSC
, Pharmaceuticals and Medical Devices Agency (PMDA), Japan